AI Maverick Intel, Inc. (AIMV)
OTCMKTS · Delayed Price · Currency is USD
0.0500
0.00 (0.00%)
At close: Mar 6, 2026
AI Maverick Intel Revenue
In the year 2013, AI Maverick Intel had annual revenue of $92.26K.
Revenue
92.26K
Revenue Growth
n/a
P/S Ratio
29.26
Revenue / Employee
18.45K
Employees
5
Market Cap
2.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2013 | 92.26K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| STRATA Skin Sciences | 30.98M |
| Fuse Medical | 18.40M |
| Escalon Medical | 12.31M |
| Vycor Medical | 1.90M |
| Co-Diagnostics | 507.89K |
| CYduct Diagnostics | 344.78K |
| Ludwig Enterprises | 207.00 |
AI Maverick Intel News
- 7 months ago - AI Maverick Intel Provides Corporate Update - Accesswire
- 8 months ago - AI Maverick Launches Enhanced Prospecting Platform to Deliver Human Like Outreach - No SDR Team Required - Accesswire
- 10 months ago - Bionoid Pharma, Inc. Confirms Name Change to AI Maverick Intel, Inc. Following Delaware Approval - Accesswire
- 10 months ago - Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation - Accesswire
- 11 months ago - Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit - Accesswire
- 11 months ago - Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements - Accesswire
- 1 year ago - Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity - Accesswire
- 1 year ago - Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm - Accesswire